Publikationen in Zusammenarbeit mit Forschern von Memorial Sloan Kettering Cancer Center (6)

2022

  1. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

    Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871

2017

  1. Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 25, pp. E4951-E4960

2013

  1. An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility

    PLoS ONE, Vol. 8, Núm. 9

  2. Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas

    Cancer Discovery, Vol. 3, Núm. 5, pp. 520-533

2012

  1. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line

    Nuclear Medicine and Biology, Vol. 39, Núm. 8, pp. 1275-1280

  2. Genome-wide analysis of Pax8 binding provides new insights into thyroid functions

    BMC Genomics, Vol. 13, Núm. 1